| Transcriptional dependencies in diffuse intrinsic pontine glioma S Nagaraja, NA Vitanza, PJ Woo, KR Taylor, F Liu, L Zhang, M Li, ... Cancer cell 31 (5), 635-652. e6, 2017 | 333 | 2017 |
| Integrated proteogenomic characterization across major histological types of pediatric brain cancer F Petralia, N Tignor, B Reva, M Koptyra, S Chowdhury, D Rykunov, A Krek, ... Cell 183 (7), 1962-1985. e31, 2020 | 208 | 2020 |
| Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis NA Vitanza, AJ Johnson, AL Wilson, C Brown, JK Yokoyama, A Künkele, ... Nature medicine 27 (9), 1544-1552, 2021 | 167 | 2021 |
| Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening GL Lin, KM Wilson, M Ceribelli, BZ Stanton, PJ Woo, S Kreimer, EY Qin, ... Science translational medicine 11 (519), eaaw0064, 2019 | 158 | 2019 |
| Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy NAP Lieberman, K DeGolier, HM Kovar, A Davis, V Hoglund, J Stevens, ... Neuro-oncology 21 (1), 83-94, 2019 | 135 | 2019 |
| MR imaging–based radiomic signatures of distinct molecular subgroups of medulloblastoma M Iv, M Zhou, K Shpanskaya, S Perreault, Z Wang, E Tranvinh, ... American Journal of Neuroradiology 40 (1), 154-161, 2019 | 105 | 2019 |
| Intraventricular B7-H3 CAR T cells for diffuse intrinsic pontine glioma: preliminary first-in-human bioactivity and safety NA Vitanza, AL Wilson, W Huang, K Seidel, C Brown, JA Gustafson, ... Cancer discovery 13 (1), 114-131, 2023 | 93 | 2023 |
| Diffuse intrinsic pontine glioma: from diagnosis to next-generation clinical trials NA Vitanza, M Monje Current treatment options in neurology 21, 1-11, 2019 | 92 | 2019 |
| Progress in diffuse intrinsic pontine glioma: advocating for stereotactic biopsy in the standard of care JR Williams, CC Young, NA Vitanza, M McGrath, AH Feroze, SR Browd, ... Neurosurgical focus 48 (1), E4, 2020 | 62 | 2020 |
| EGFR806-CAR T cells selectively target a tumor-restricted EGFR epitope in glioblastoma AC Ravanpay, J Gust, AJ Johnson, LS Rolczynski, M Cecchini, CA Chang, ... Oncotarget 10 (66), 7080, 2019 | 60 | 2019 |
| Pediatric ependymoma NA Vitanza, S Partap Journal of child neurology 31 (12), 1354-1366, 2016 | 60 | 2016 |
| Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models NA Vitanza, MC Biery, C Myers, E Ferguson, Y Zheng, EJ Girard, ... Neuro-oncology 23 (3), 376-386, 2021 | 55 | 2021 |
| Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies IJ Findlay, GN De Iuliis, RJ Duchatel, ER Jackson, NA Vitanza, JE Cain, ... Oncogene 41 (4), 461-475, 2022 | 54 | 2022 |
| The biology of relapsed acute lymphoblastic leukemia: opportunities for therapeutic interventions T Bhatla, CL Jones, JA Meyer, NA Vitanza, EA Raetz, WL Carroll Journal of pediatric hematology/oncology 36 (6), 413-418, 2014 | 52 | 2014 |
| Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma E Cantor, K Wierzbicki, RS Tarapore, K Ravi, C Thomas, R Cartaxo, ... Neuro-oncology 24 (8), 1366-1374, 2022 | 50 | 2022 |
| Deep learning for pediatric posterior fossa tumor detection and classification: a multi-institutional study JL Quon, W Bala, LC Chen, J Wright, LH Kim, M Han, K Shpanskaya, ... American Journal of Neuroradiology 41 (9), 1718-1725, 2020 | 50 | 2020 |
| Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas JM Przystal, C Cianciolo Cosentino, S Yadavilli, J Zhang, S Laternser, ... Neuro-oncology 24 (9), 1438-1451, 2022 | 48 | 2022 |
| Histone deposition pathways determine the chromatin landscapes of H3. 1 and H3. 3 K27M oncohistones JF Sarthy, MP Meers, DH Janssens, JG Henikoff, H Feldman, ... Elife 9, e61090, 2020 | 46 | 2020 |
| Ikaros deletions in BCR–ABL‐negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance NA Vitanza, W Zaky, R Blum, JA Meyer, J Wang, T Bhatla, DJ Morrison, ... Pediatric blood & cancer 61 (10), 1779-1785, 2014 | 37 | 2014 |
| Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma RJ Duchatel, A Mannan, AS Woldu, T Hawtrey, PA Hindley, AM Douglas, ... Neuro-oncology advances 3 (1), vdab169, 2021 | 35 | 2021 |
Michelle Monje-DeisserothProfessor of Neurology, Howard Hughes Medical Institute Investigator, Stanford UniversityVerified email at stanford.edu
